A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis

T Sawicki, M Ruszkowska, A Danielewicz… - Cancers, 2021 - mdpi.com
Simple Summary According to the available data, colorectal cancer (CRC) is one of the most
common malignant neoplasms. Depending on the location, type of cancer or gender, it is …

Risk of colorectal cancer in inflammatory bowel diseases

MS Nadeem, V Kumar, FA Al-Abbasi, MA Kamal… - Seminars in cancer …, 2020 - Elsevier
Inflammatory bowel diseases (IBDs) are chronic problems of gastrointestinal tract (GIT) with
poorly understood aetiology. Patients with any of the two common entities, Crohn's disease …

Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology …

KJ Monahan, MM Davies, M Abulafi, A Banerjea… - Gut, 2022 - gut.bmj.com
Faecal immunochemical testing (FIT) has a high sensitivity for the detection of colorectal
cancer (CRC). In a symptomatic population FIT may identify those patients who require …

A risk-stratified approach to colorectal cancer prevention and diagnosis

MA Hull, CJ Rees, L Sharp, S Koo - Nature Reviews Gastroenterology & …, 2020 - nature.com
Population screening and endoscopic surveillance are used widely to prevent the
development of and death from colorectal cancer (CRC). However, CRC remains a major …

[HTML][HTML] LSE–Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19

M Anderson, E Pitchforth, M Asaria, C Brayne… - The Lancet, 2021 - thelancet.com
The UK has recorded one of the highest death rates associated with COVID-19 globally,
whether measured as deaths that are directly attributable to COVID-19 or by excess …

Diagnostic performance of a faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: an evaluation in the South West of …

SER Bailey, GA Abel, A Atkins, R Byford… - British Journal of …, 2021 - nature.com
Background The faecal immunochemical test (FIT) was introduced to triage patients with low-
risk symptoms of possible colorectal cancer in English primary care in 2017, underpinned by …

Faecal immunochemical testing for adults with symptoms of colorectal cancer attending English primary care: a retrospective cohort study of 14 487 consecutive test …

BD Nicholson, T James, M Paddon… - Alimentary …, 2020 - Wiley Online Library
Background Faecal immunochemical testing (FIT) is recommended by the National Institute
for Health and Care Excellence (NICE) to triage symptomatic primary care patients for further …

Impact of introducing a faecal immunochemical test (FIT) for haemoglobin into primary care on the outcome of patients with new bowel symptoms: a prospective cohort …

C Mowat, J Digby, JA Strachan… - BMJ open …, 2019 - bmjopengastro.bmj.com
Objective To determine whether a faecal immunochemical test (FIT) for faecal haemoglobin
concentration (f-Hb) can be safely implemented in primary care as a rule-out test for …

Role of the faecal immunochemical test in patients with risk-stratified suspected colorectal cancer symptoms: A systematic review and meta-analysis to inform the …

R Booth, R Carten, N D'Souza, M Westwood… - The Lancet Regional …, 2022 - thelancet.com
Summary Background The UK National Institute for Health and Care Excellence (NICE),
recommended in 2017 the use of the faecal immunochemical test (FIT) to guide …

Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer

C Chapman, J Bunce, S Oliver, O Ng, A Tangri… - BJS open, 2019 - academic.oup.com
Background New national guidance on urgent referral for investigation of colorectal cancer
included faecal occult blood testing in 2015. A service evaluation of faecal immunochemical …